Shalby
Ticker > Company >

Shalby share price

Shalby Ltd.

NSE: SHALBY BSE: 540797 SECTOR: Hospital & Healthcare Services  70.61 K   123   21

227.15
+0.75 (0.33%)
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 233

Today's Low

₹ 225.8

52 Week High

₹ 295.65

52 Week Low

₹ 177.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2453.44 Cr.

Enterprise Value

₹ 2558.24 Cr.

No. of Shares

10.8 Cr.

P/E

31.12

P/B

2.11

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  107.42

CASH

₹ 9.23 Cr.

DEBT

₹ 114.02 Cr.

Promoter Holding

74.27 %

EPS (TTM)

₹  7.3

Sales Growth

17.18%

ROE

10.23 %

ROCE

14.97%

Profit Growth

28.51 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.18%
3 Year25.61%
5 Year12.4%

Profit Growth

1 Year28.51%
3 Year34.29%
5 Year26.47%

ROE%

1 Year10.23%
3 Year8.93%
5 Year7.08%

ROCE %

1 Year14.97%
3 Year13.08%
5 Year10.69%

Debt/Equity

0.1074

Price to Cash Flow

17.55

Interest Cover Ratio

37.6885

CFO/PAT (5 Yr. Avg.)

1.65858824325031

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 74.27 0.00
Mar 2025 74.27 0.00
Dec 2024 74.27 0.00
Sep 2024 74.25 0.00
Jun 2024 74.25 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 34.289978613002% for the Past 3 years.
  • The company has shown a good revenue growth of 25.6066998821934% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 37.6885.
  • The company has an efficient Cash Conversion Cycle of -2571.7751 days.
  • Company has a healthy liquidity position with current ratio of 3.9925.
  • The company has a good cash flow management; CFO/PAT stands at 1.65858824325031.
  • The company has a high promoter holding of 74.27%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 232.72 212.27 220.64 207.06 236.65
Total Expenditure 182.38 176.81 178.11 176.23 189.81
Operating Profit 50.34 35.46 42.53 30.83 46.84
Other Income 7.71 5.29 6.28 7.14 5.52
Interest 2.67 2.7 3.09 2.66 2.58
Depreciation 9.54 9.78 9.94 9.63 9.68
Exceptional Items 0 0 0 0 0
Profit Before Tax 45.84 28.28 35.77 25.68 40.1
Tax 15.37 10.95 14.91 10.72 14.41
Profit After Tax 30.47 17.33 20.86 14.96 25.7
Adjusted EPS (Rs) 2.83 1.61 1.94 1.39 2.39

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 483.89 418.67 646.8 708.02 829.68
Total Expenditure 401.33 331.63 515.54 564.72 650.69
Operating Profit 82.56 87.04 131.26 143.3 179
Other Income 17.74 9.62 13 19.57 20.7
Interest 7.41 4.5 4.4 4.44 4.32
Depreciation 35.86 36.67 35.5 37.07 37.08
Exceptional Items 0 0 -4.44 0 0
Profit Before Tax 57.03 55.49 99.92 121.36 158.31
Tax 29.06 12.61 30.11 40.55 54.47
Net Profit 27.97 42.88 69.81 80.81 103.85
Adjusted EPS (Rs.) 2.59 3.97 6.46 7.53 9.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 108.01 108.01 108.01 107.31 107.41
Total Reserves 705.78 741.64 798.71 863.01 954.76
Borrowings 48.67 35.5 25.33 14.61 103.12
Other N/C liabilities 95.89 114.47 146.44 185.04 211.06
Current liabilities 83.25 82.37 97.31 105.01 108.16
Total Liabilities 1041.6 1081.99 1175.8 1274.98 1484.51
Assets
Net Block 669.82 657.58 628.18 602.83 599.28
Capital WIP 3.02 3.99 4.48 5.67 5.24
Intangible WIP 3.37 3.53 1.25 4.38 0
Investments 10.65 11.79 36.6 74.9 280.82
Loans & Advances 110.72 120.3 145.41 172.74 166.01
Other N/C Assets 3.37 7.61 2.57 1.53 1.33
Current Assets 240.65 277.2 357.31 412.93 431.82
Total Assets 1041.6 1081.99 1175.8 1274.98 1484.51
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 57.03 55.49 99.92 121.36 158.31
Adjustment 36.82 36.75 41.29 27.59 26.31
Changes in Assets & Liabilities -16.75 -5.76 -17.48 42.65 -25.09
Tax Paid -20.02 -9.24 -22.81 -27.07 -19.77
Operating Cash Flow 57.09 77.24 100.93 164.53 139.77
Investing Cash Flow -32.28 -51.83 -40.32 -172.4 -206.01
Financing Cash Flow -21.5 -27.82 -17.25 -38.21 72.14
Net Cash Flow 3.31 -2.41 43.36 -46.09 5.91

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 74.25 74.25 74.27 74.27 74.27
darshini vikram shah 2.79 2.79 2.79 2.79 2.79
shah family trust throuh ... 34.73 34.73 34.73 34.73 34.73
shanay vikram shah 0.13 0.13 0.13 0.13 0.13
vikram indrajit shah 7.39 7.39 7.41 7.41 7.41
zodiac mediquip limited 29.21 29.21 29.21 29.21 29.21
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Jun 2025%
investors 25.88 25.88 25.76 25.75 25.73
first water fund - - - - 1.77
polus global fund 1.03 1.03 1.03 1.03 -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura
Research Monarch Networth Capital
Research HDFC Securities
Research Monarch Networth Capital

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY21
Concall Q3FY24
Concall Q3FY22
Concall Q3FY21
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q1FY22
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY23
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

Shalby informs about investor meet 5 Sep, 11:20 AM Shalby Academy enters into MoU with BSDU 25 Aug, 4:59 PM Shalby - Quaterly Results 13 Aug, 4:44 PM Shalby - Quaterly Results 13 Aug, 4:44 PM Shalby enters into MoU with SVVV, Indore 9 Jul, 9:59 AM Shalby informs about compliance certificate 5 Jul, 11:47 AM Shalby informs about updates 20 Jun, 2:58 PM Shalby - Quaterly Results 29 May, 8:27 PM Shalby - Quaterly Results 29 May, 8:27 PM Shalby informs about scrutinizers report 15 Mar, 4:06 PM Shalby informs about notice of postal ballot 10 Feb, 5:17 PM Shalby - Quaterly Results 3 Feb, 7:36 PM Shalby - Quaterly Results 3 Feb, 7:36 PM Shalby launches Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad 16 Jan, 3:57 PM Shalby’s step down arm receives USFDA’s approval for Duraniom 16 Jan, 11:09 AM Shalby informs about earnings call transcript 6 Nov, 3:10 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby informs about earnings conference call 25 Oct, 12:18 PM Shalby informs about updates 3 Oct, 5:30 PM Shalby opens Orthopedics Centre of Excellence in Rajkot 5 Aug, 9:20 AM Shalby informs about exercise of stock option under ESOS 22 Jul, 4:57 PM Shalby to execute lease agreement to construct new healthcare facility in Mumbai 11 Jul, 12:14 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby informs about change in mode of investor call 5 Jul, 11:59 AM Shalby informs about investor conference call 2 Jul, 11:37 AM Shalby informs about trading window closure 26 Jun, 4:30 PM Shalby informs about disclosure 6 Jun, 1:06 PM Shalby - Quaterly Results 28 May, 2:42 PM Shalby - Quaterly Results 28 May, 2:42 PM Shalby’s step-down arm incorporates Wholly-Owned Subsidiary in India 12 Apr, 9:26 AM Shalby informs about compliance certificate 3 Apr, 5:22 PM Shalby informs about compliance certificate 2 Apr, 3:05 PM Shalby to avail term loan facility from Bajaj Finance to acquire Healers Hospital 15 Mar, 11:09 AM Shalby to acquire 100% equity stake in Healers Hospital 13 Mar, 10:15 AM Shalby submits intimation of grant of options under Shalby ESOS - 2021 7 Feb, 5:23 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby acquires majority stake in Sanar International hospitals 18 Jan, 4:23 PM Shalby’s healthcare education division signs MoU with Kaushalya 11 Jan, 6:15 PM Shalby informs about compliances-certificate 3 Jan, 4:45 PM Shalby’s arm gets nod to invest in Shalby Global Technologies 18 Dec, 2:37 PM Shalby gets nod for availing of enhanced renewed SBLC facility 13 Dec, 11:21 AM Shalby informs about change in senior management 28 Nov, 2:50 PM Shalby executes amendment agreement for hospital building in Mumbai 23 Nov, 10:57 AM Shalby informs about disclosure 22 Nov, 5:29 PM

Shalby Stock Price Analysis and Quick Research Report. Is Shalby an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shalby. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shalby has a PE ratio of 31.0282473492424 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shalby has ROA of 7.5264% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shalby has a Current ratio of 3.9925.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shalby has a ROE of 10.2267%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Shalby has a Debt to Equity ratio of 0.1074 which means that the company has low proportion of debt in its capital.

  • Sales growth: Shalby has reported revenue growth of 17.1841% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Shalby for the current financial year is 21.5741433776515%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shalby is Rs 1.2 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shalby is Rs 7.2998. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shalby in Ticker for free. Also, one can get the intrinsic value of Shalby by using Valuation Calculators, which are available with a Finology ONE subscription. 

Shalby FAQs

Q1. What is Shalby share price today?
Ans: The current share price of Shalby is Rs 226.5.

Q2. What is the market capitalisation of Shalby?
Ans: Shalby has a market capitalisation of Rs 2446.4212905 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Shalby?
Ans: The PE ratio of Shalby is 31.0282473492424 and the P/B ratio of Shalby is 2.10859889421909, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Shalby share?
Ans: The 52-week high share price of Shalby is Rs 296, and the 52-week low share price of Shalby is Rs 177.25.

Q5. Does Shalby pay dividends?
Ans: Currently, Shalby does not pay dividends. Dividend yield of Shalby is around 0%.

Q6. What are the face value and book value of Shalby shares?
Ans: The face value of Shalby shares is Rs 10, while the book value per share of Shalby is around Rs 107.4173. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Shalby?
Ans: Shalby has a total debt of Rs 114.024 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Shalby?
Ans: The ROE of Shalby is 10.2267% and ROCE of Shalby is 14.9746%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Shalby a good buy for the long term?
Ans: The Shalby long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Shalby undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Shalby appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Shalby’s financials?
Ans: You can review Shalby’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Shalby

Shalby Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Shalby Ltd. is a leading healthcare service provider in India. Established in 1994 by Dr. Vikram I. Shah, a renowned orthopedic surgeon, the company has grown to become one of the largest multi-specialty hospitals in the country. With a focus on excellence in patient care and advanced medical treatments, Shalby Ltd. has gained a reputation for its quality services in various healthcare disciplines.

Shalby Ltd. - Share Price

At our website, you can easily track the real-time and historical share prices of Shalby Ltd. Our pre-built screening tools provide a convenient way to analyze the company's stock performance and compare it with industry peers. Whether you are a long-term investor or simply interested in monitoring the stock, you can rely on our comprehensive share price data.

Shalby Ltd. - Balance Sheet

The balance sheet of Shalby Ltd. provides an insight into the company's financial position, assets, and liabilities. By studying the balance sheet, investors can evaluate the company's solvency, liquidity, and capital structure. Our website offers downloadable annual reports that include the detailed balance sheet information for Shalby Ltd. Additionally, our premium features allow users to perform fair value calculations using tools like DCF (Discounted Cash Flow) Analysis and BVPS (Book Value per Share) Analysis.

Shalby Ltd. - Annual Report

The annual report of Shalby Ltd. provides a comprehensive review of the company's performance, achievements, and future growth prospects. Investors can gain valuable insights into the company's financials, strategic initiatives, and market outlook through these reports. Our website offers annual reports as downloadable files, making it convenient for users to access and analyze the information.

Shalby Ltd. - Dividend

Dividends are an important aspect for investors considering long-term stock investments. The dividend policy of Shalby Ltd. is aimed at rewarding shareholders for their investment. By studying the company's dividend history, investors can assess the stability and growth of the dividend payments. Our website provides detailed dividend information for Shalby Ltd., enabling users to analyze the company's dividend policy and track dividend announcements.

Shalby Ltd. - Quarterly Results

Quarterly results are important indicators of a company's financial performance and its ability to meet targets. At our website, users can access the quarterly results of Shalby Ltd. and analyze key financial metrics such as revenues, profits, and margins. Our premium features allow users to perform fair value calculations using tools like Earnings Multiple Approach and DuPont Analysis, which can provide a deeper understanding of the company's financial health and performance.

Shalby Ltd. - Stock Price

Tracking the stock price of Shalby Ltd. is essential for investors to make informed investment decisions. Our website offers real-time stock price information along with historical data. Users can analyze price trends, patterns, and volatility through our comprehensive price charts. Our pre-built screening tools can help investors assess the stock's performance relative to market benchmarks and industry peers.

Shalby Ltd. - Price Chart

Our website provides detailed price charts for Shalby Ltd., allowing users to visualize the stock's performance over time. Whether you are analyzing short-term price fluctuations or long-term trends, our interactive charts offer a comprehensive view of the stock's price movements. By using our pre-built screening tools, users can identify potential investment opportunities based on technical analysis and trend indicators.

Shalby Ltd. - News

Staying updated with the latest news about Shalby Ltd. is crucial for investors. Our website provides a dedicated news section where users can access the latest developments, announcements, and market news related to the company. Whether it's news about expansion plans, new partnerships, or regulatory updates, users can rely on our platform to stay informed about Shalby Ltd.

Shalby Ltd. - Concall Transcripts

Concall transcripts offer valuable insights into the discussions and deliberations during the company's conference calls with analysts and investors. Our website provides downloadable concall transcripts for Shalby Ltd., allowing users to gain firsthand knowledge about the company's performance, strategies, and management outlook. These transcripts enable investors to make informed decisions based on the analysis of management discussions and market commentary.

Shalby Ltd. - Investor Presentations

Investor presentations are an effective way for companies to communicate their vision, strategy, and financial performance to investors. Our website offers downloadable investor presentations for Shalby Ltd., providing users with in-depth information about the company's business model, growth prospects, and market positioning. By studying these presentations, investors can gain a better understanding of the company's value proposition and make informed investment decisions.

Shalby Ltd. - Promoters

The promoters of Shalby Ltd. play a crucial role in the company's growth and success. Our website provides comprehensive information about the promoters of Shalby Ltd, including their background, experience, and contribution to the company's development. Investors can evaluate the credibility and expertise of the promoters, which can influence their investment decisions.

Shalby Ltd. - Shareholders

Understanding the shareholder base of Shalby Ltd. can provide insights into the company's ownership structure and investor sentiment. Our website offers information about the major shareholders of Shalby Ltd., including institutional investors and individual shareholders. Investors can analyze the shareholding pattern and changes in ownership, which can be useful in assessing market perception and potential voting rights in the company.

By providing comprehensive information about Shalby Ltd.'s company profile, share price, balance sheet, annual report, dividend, quarterly results, stock price, price chart, news, concall transcripts, investor presentations, promoters, and shareholders, our website aims to cater to the needs of long-term stock investors seeking detailed stock analysis. We also offer premium features that allow fair value calculation using tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. Users can access and download annual reports, concall transcripts, investor presentations, credit ratings, and research reports to make well-informed investment decisions. 

Shalby Balance Sheet Overview

In the comprehensive analysis of Shalby's balance sheet from March 2020 to March 2024, we observe a steady increase in Total Liabilities and Assets, signifying growth. Examining the individual components provides deeper insights into the company's financial health and strategic positioning.

Shalby's Equity and Reserves

The Share Capital of Shalby shows a slight modification, moving from Rs 108.01 Cr. in March 2020 to Rs 107.41 Cr. in March 2024. However, a significant increase in Total Reserves from Rs 705.78 Cr. to Rs 954.76 Cr. during the same period highlights the company's ability to accumulate profits and reinforce its financial foundation.

Shalby's Debt Analysis

Looking at Shalby's borrowings, there was a noteworthy reduction from Rs 48.67 Cr. in March 2020 to Rs 14.61 Cr. in March 2023, before a sharp increase to Rs 103.12 Cr. in March 2024. This fluctuation warrants a close watch for understanding the company's debt management strategy.

Shalby's Assets Insight

The Net Block has seen a gradual decrease, suggesting asset depreciation or disposals; from Rs 669.82 Cr. in 2020 to Rs 599.28 Cr. in 2024. On the other hand, Investments surged impressively to Rs 280.82 Cr. from a mere Rs 10.65 Cr., indicating strategic asset reallocation or investment activities.

Moreover, the Current Assets growth, from Rs 240.65 Cr. in March 2020 to Rs 431.82 Cr. in March 2024, showcases robust operational efficiency and liquidity management.

This data reflects an analysis for the Standalone Balance Sheet of the company, equipping investors with critical insights for a comprehensive stock screening process.

Additionally, Shalby's evolving financials play a significant role in the healthcare sector's dynamics on platforms like NSE and BSE, influencing investor sentiments across the spectrum.

Read More
X